{"disease":{"id":"hemophilia-a-hemophilia-b","name":"hemophilia a hemophilia b"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06820515","title":"ATHNdataset Registry","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":200000,"lead_sponsor_name":"American Thrombosis and Hemostasis Network","has_results":false},{"nct_id":"NCT03655223","title":"Early Check: Expanded Screening in Newborns","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":30000,"lead_sponsor_name":"RTI International","has_results":false},{"nct_id":"NCT05687474","title":"Baby Detect : Genomic Newborn Screening","phase":"","overall_status":"COMPLETED","enrollment_count":6824,"lead_sponsor_name":"Centre Hospitalier Universitaire de Liege","has_results":false},{"nct_id":"NCT06727669","title":"Longitudinal Cohort of Thrombosis and Hemostasis Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT04645199","title":"National Longitudinal Cohort of Hematological Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":2300,"lead_sponsor_name":"Institute of Hematology & Blood Diseases Hospital, China","has_results":false},{"nct_id":"NCT03533504","title":"Web Accessible Population Pharmacokinetics Service - Hemophilia: Sources of Variability","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"McMaster University","has_results":false},{"nct_id":"NCT02912143","title":"German Pediatric Hemophilia Research Database","phase":"","overall_status":"RECRUITING","enrollment_count":800,"lead_sponsor_name":"Goethe University","has_results":false},{"nct_id":"NCT03615053","title":"Personalized Medicine for Canadians With Hemophilia","phase":"NA","overall_status":"UNKNOWN","enrollment_count":600,"lead_sponsor_name":"McMaster University","has_results":false},{"nct_id":"NCT06158334","title":"Study of Surgical Practices in Patients With Haemophilia A or B Treated With an Extended Half-life Recombinant Factor VIII-Fc or IX-Fc (ELOCTA®, ALPROLIX®)","phase":"","overall_status":"UNKNOWN","enrollment_count":400,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT03619863","title":"ATHN 7: Hemophilia Natural History Study","phase":"","overall_status":"COMPLETED","enrollment_count":395,"lead_sponsor_name":"American Thrombosis and Hemostasis Network","has_results":false},{"nct_id":"NCT05145127","title":"Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":245,"lead_sponsor_name":"Pfizer","has_results":false},{"nct_id":"NCT03185897","title":"Global Epidemiologic Study of Preexisting Immunity to AAV in Adults With Severe Hemophilia","phase":"","overall_status":"COMPLETED","enrollment_count":242,"lead_sponsor_name":"Baxalta now part of Shire","has_results":false},{"nct_id":"NCT03818529","title":"ATHN 8: Previously Untreated Patients (PUPs) Matter Study","phase":"","overall_status":"COMPLETED","enrollment_count":237,"lead_sponsor_name":"American Thrombosis and Hemostasis Network","has_results":false},{"nct_id":"NCT05187936","title":"Pre-clinical Models for Mesenchymal Stem Cell Therapy in Hemophilic Arthropathy","phase":"","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false},{"nct_id":"NCT07101224","title":"Data Registry in Chinese Hemophilia A and B Patients","phase":"","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"Institute of Hematology & Blood Diseases Hospital, China","has_results":false},{"nct_id":"NCT03938792","title":"Study of the Efficacy and Safety PF-06741086 in Adult and Teenage Participants With Severe Hemophilia A or Moderately Severe to Severe Hemophilia B","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":189,"lead_sponsor_name":"Pfizer","has_results":false},{"nct_id":"NCT04731701","title":"Psychometric Validation of the Hemophilia Functional Ability Scoring Tool (Hemo-FAST)","phase":"","overall_status":"COMPLETED","enrollment_count":180,"lead_sponsor_name":"Swedish Orphan Biovitrum","has_results":false},{"nct_id":"NCT05568719","title":"Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":173,"lead_sponsor_name":"Pfizer","has_results":false},{"nct_id":"NCT06569108","title":"Efficacy and Safety of KN057 Prophylaxis in Patients With Haemophilia A or B Without Inhibitors","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":125,"lead_sponsor_name":"Suzhou Alphamab Co., Ltd.","has_results":false},{"nct_id":"NCT03417245","title":"A Study of Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients Without Inhibitors","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"Genzyme, a Sanofi Company","has_results":true},{"nct_id":"NCT05605678","title":"Hemophilia Non-Interventional Study Prior to SerpinPC Intervention (PRESent-5)","phase":"","overall_status":"TERMINATED","enrollment_count":108,"lead_sponsor_name":"ApcinteX Ltd","has_results":false},{"nct_id":"NCT05606640","title":"Gaining Insight Into the Complexity of Pain in Patients With Haemophilia","phase":"","overall_status":"COMPLETED","enrollment_count":104,"lead_sponsor_name":"Universiteit Antwerpen","has_results":false},{"nct_id":"NCT05439642","title":"Validation and Reliability of the CHO-KLAT in Turkish","phase":"NA","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Yuzuncu Yil University","has_results":false},{"nct_id":"NCT05611801","title":"A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Pfizer","has_results":false},{"nct_id":"NCT02740413","title":"Treatment Patterns And Outcomes In Patients Treated With Benefix Or Refacto/Refacto AF - A Swedish Cohort Study","phase":"","overall_status":"COMPLETED","enrollment_count":86,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT02190149","title":"Study of Prophylaxis, ACtivity and Effectiveness (SPACE) in Hemophilia Patients Currently Treated With ADVATE or RIXUBIS","phase":"","overall_status":"COMPLETED","enrollment_count":64,"lead_sponsor_name":"Baxalta now part of Shire","has_results":false},{"nct_id":"NCT03417102","title":"A Study of Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients With Inhibitors","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Genzyme, a Sanofi Company","has_results":true},{"nct_id":"NCT05789524","title":"The Efficacy and Safety of SerpinPC in Participants with Severe Hemophilia a or Moderately Severe to Severe Hemophilia B","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":60,"lead_sponsor_name":"ApcinteX Ltd","has_results":false},{"nct_id":"NCT05980377","title":"Patterns of Hemophilia Care in Assiut Children Patients","phase":"","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT04647227","title":"SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":55,"lead_sponsor_name":"American Thrombosis and Hemostasis Network","has_results":false},{"nct_id":"NCT05804734","title":"Vitamin K Antagonist Versus Direct Oral Anticoagulant Treatments in Hemophilia","phase":"","overall_status":"COMPLETED","enrollment_count":54,"lead_sponsor_name":"Groupe Maladies hémorragiques de Bretagne","has_results":false},{"nct_id":"NCT06312475","title":"Efficacy and Safety of KN057 Prophylaxis in Patients With Haemophilia A or B With Inhibitors","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":53,"lead_sponsor_name":"Suzhou Alphamab Co., Ltd.","has_results":false},{"nct_id":"NCT00851721","title":"Efficacy and Safety Study of Prophylactic Versus On-Demand Treatment With Feiba NF in Subjects With Hemophilia A or B and a High Titer Inhibitor","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":52,"lead_sponsor_name":"Baxalta now part of Shire","has_results":true},{"nct_id":"NCT02035605","title":"A Phase 1 Study of an Investigational Drug, ALN-AT3SC, in Healthy Volunteers and Hemophilia A or B Patients","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":51,"lead_sponsor_name":"Sanofi","has_results":false},{"nct_id":"NCT06565481","title":"Measurement Properties in People with Hemophilia","phase":"NA","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"University of Zurich","has_results":false},{"nct_id":"NCT05889754","title":"Reliability and Validity of the Turkish Version of the PedHAL","phase":"","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"Hasan Kalyoncu University","has_results":false},{"nct_id":"NCT06809972","title":"Synovial Proliferation on Routine Ultrasound: Active or Inactive?","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":46,"lead_sponsor_name":"Van Creveldkliniek","has_results":false},{"nct_id":"NCT05879549","title":"Comparison of Efficiency of Closed Kinetic Chain Exercises Versus Proprioceptive Exercises Patient With Hemophilia","phase":"NA","overall_status":"COMPLETED","enrollment_count":46,"lead_sponsor_name":"Bahçeşehir University","has_results":false},{"nct_id":"NCT06025552","title":"Study of TU7710 in Warfarin Anti-coagulated Healthy Male Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"TiumBio Co., Ltd.","has_results":false},{"nct_id":"NCT05981313","title":"Viscoelastic Properties of Lower Extremity Muscles in Patients With Hemophilia","phase":"","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"Hasan Kalyoncu University","has_results":false},{"nct_id":"NCT01757405","title":"Recombinant Factor VIIa BI (rFVIIa BI) Treatment of Acute Bleeding Episodes Per an On-demand Regimen","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Baxalta now part of Shire","has_results":true},{"nct_id":"NCT04073498","title":"The Safety and Tolerability of SerpinPC in Healthy Men and in Men with Severe Blood Disorders (haemophilia a and B)","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":39,"lead_sponsor_name":"ApcinteX Ltd","has_results":false},{"nct_id":"NCT02554773","title":"An Open-label Extension Study of an Investigational Drug, Fitusiran, in Patients With Moderate or Severe Hemophilia A or B","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":34,"lead_sponsor_name":"Genzyme, a Sanofi Company","has_results":true},{"nct_id":"NCT02571569","title":"A Single Escalating Dose and Multiple Dose Study of BAY 1093884 in Subjects With Severe Hemophilia Types A or B, With or Without Inhibitors","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT06349473","title":"A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency)","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":31,"lead_sponsor_name":"Equilibra Bioscience LLC","has_results":false},{"nct_id":"NCT05651061","title":"A Phase I of SS109 in Hemophilia A or and B With Inhibitors","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":27,"lead_sponsor_name":"Jiangsu Gensciences lnc.","has_results":false},{"nct_id":"NCT02448680","title":"A Phase III Study on the Safety, Pharmacokinetics and Efficacy of Coagulation Factor VIIa","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"Laboratoire français de Fractionnement et de Biotechnologies","has_results":true},{"nct_id":"NCT02484638","title":"Study of Recombinant Factor VIIa Fusion Protein (rVIIa-FP, CSL689) for On-demand Treatment of Bleeding Episodes in Patients With Hemophilia A or B With Inhibitors","phase":"PHASE2, PHASE3","overall_status":"TERMINATED","enrollment_count":25,"lead_sponsor_name":"CSL Behring","has_results":false},{"nct_id":"NCT06014320","title":"Alterations in Coagulation Factor Levels in Patients With End Stage Liver Disease","phase":"","overall_status":"UNKNOWN","enrollment_count":25,"lead_sponsor_name":"Stanford University","has_results":false},{"nct_id":"NCT04768699","title":"Study of Recombinant Human Coagulation Factor VIIa for Injection (FⅦa) in Patients With Hemophilia.","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":24,"lead_sponsor_name":"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}